Total Payments
$1,072
2024 Payments
$46.66
Companies
10
Transactions
25
Medicare Patients
5,523
Medicare Billing
$1.3M

Payment Breakdown by Category

Food & Beverage$1,072 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,072 25 100.0%

Top Paying Companies

Company Total Records Latest Year
PFIZER INC. $445.60 12 $0 (2019)
Merck Sharp & Dohme Corporation $139.48 2 $0 (2017)
Gilead Sciences, Inc. $124.94 1 $0 (2023)
Otsuka America Pharmaceutical, Inc. $122.52 1 $0 (2018)
Chiesi USA, Inc. $88.70 1 $0 (2018)
Sumitomo Pharma America, Inc. $46.66 2 $0 (2024)
Janssen Pharmaceuticals, Inc $41.56 2 $0 (2022)
Fresenius USA Marketing, Inc. $30.24 2 $0 (2022)
Bayer HealthCare Pharmaceuticals Inc. $20.22 1 $0 (2021)
Horizon Therapeutics plc $12.45 1 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $46.66 2 Sumitomo Pharma America, Inc. ($46.66)
2023 $124.94 1 Gilead Sciences, Inc. ($124.94)
2022 $38.53 2 Janssen Pharmaceuticals, Inc ($19.99)
2021 $20.22 1 Bayer HealthCare Pharmaceuticals Inc. ($20.22)
2019 $238.71 5 PFIZER INC. ($226.26)
2018 $422.67 9 PFIZER INC. ($178.18)
2017 $180.64 5 Merck Sharp & Dohme Corporation ($139.48)

All Payment Transactions

25 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
11/26/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $21.76 General
Category: UROLOGY
09/25/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $24.90 General
Category: UROLOGY
08/01/2023 Gilead Sciences, Inc. Veklury (Drug) Food and Beverage In-kind items and services $124.94 General
Category: COVID-19
03/18/2022 Fresenius USA Marketing, Inc. Velphoro (Drug) Food and Beverage In-kind items and services $18.54 General
Category: Phosphate binder for ESRD
01/20/2022 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $19.99 General
Category: Cardiovascular & Metabolism
09/11/2021 Bayer HealthCare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $20.22 General
Category: Cardio-renal
10/30/2019 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $93.33 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
10/17/2019 PFIZER INC. ELIQUIS (Drug), VYNDAQEL Food and Beverage In-kind items and services $13.16 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
10/16/2019 Horizon Therapeutics plc KRYSTEXXA (Biological) Food and Beverage In-kind items and services $12.45 General
Category: KRYSTEXXA
06/25/2019 PFIZER INC. VYNDAQEL (Drug) Food and Beverage In-kind items and services $105.93 General
Category: CARDIOVASCULAR
01/17/2019 PFIZER INC. CHANTIX (Drug), ELIQUIS Food and Beverage In-kind items and services $13.84 General
Category: NEUROSCIENCE;TOBACCO DEPENDENCE
11/09/2018 PFIZER INC. CHANTIX (Drug), ELIQUIS Food and Beverage In-kind items and services $13.28 General
Category: NEUROSCIENCE;TOBACCO DEPENDENCE
09/25/2018 Chiesi USA, Inc. CLEVIPREX (Drug) Food and Beverage Cash or cash equivalent $88.70 General
Category: CARDIOVASCULAR
09/15/2018 PFIZER INC. CHANTIX (Drug), ELIQUIS Food and Beverage In-kind items and services $16.36 General
Category: NEUROSCIENCE;TOBACCO DEPENDENCE
09/12/2018 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $21.57 General
Category: Cardiovascular & Metabolism
09/06/2018 PFIZER INC. CHANTIX (Drug), ELIQUIS Food and Beverage In-kind items and services $11.08 General
Category: NEUROSCIENCE;TOBACCO DEPENDENCE
08/08/2018 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $125.00 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
07/19/2018 Fresenius USA Marketing, Inc. Velphoro (Drug) Food and Beverage In-kind items and services $11.70 General
Category: Phosphate binder for ESRD
03/09/2018 PFIZER INC. CHANTIX (Drug), ELIQUIS Food and Beverage In-kind items and services $12.46 General
Category: NEUROSCIENCE;TOBACCO DEPENDENCE
02/27/2018 Otsuka America Pharmaceutical, Inc. SAMSCA (Drug) Food and Beverage In-kind items and services $122.52 General
Category: NEPHROLOGY
09/20/2017 PFIZER INC. CHANTIX (Drug), ELIQUIS Food and Beverage In-kind items and services $13.24 General
Category: NEUROSCIENCE;TOBACCO DEPENDENCE
08/16/2017 Merck Sharp & Dohme Corporation ZERBAXA (Drug), SIVEXTRO Food and Beverage In-kind items and services $14.48 General
Category: INFECTIOUS DISEASE
06/05/2017 PFIZER INC. CHANTIX (Drug), ELIQUIS Food and Beverage In-kind items and services $13.11 General
Category: NEUROSCIENCE;TOBACCO DEPENDENCE
03/08/2017 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $14.81 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
02/08/2017 Merck Sharp & Dohme Corporation ZERBAXA (Drug) Food and Beverage In-kind items and services $125.00 General
Category: INFECTIOUS DISEASE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 10 1,074 4,148 $711,590 $295,313
2022 13 1,216 4,273 $748,150 $293,775
2021 14 1,631 5,590 $978,495 $388,216
2020 14 1,602 4,911 $893,205 $335,741
Total Patients
5,523
Total Services
18,922
Medicare Billing
$1.3M
Procedure Codes
51

All Medicare Procedures & Services

51 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 400 3,010 $451,500 $181,786 40.3%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 351 476 $119,000 $46,972 39.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 141 264 $33,000 $16,701 50.6%
90961 Dialysis services, 2-3 physician visits per month (20 years or older) Office 2023 15 57 $28,500 $12,968 45.5%
90960 Dialysis services, 4 or more physician visits per month (20 years or older) Office 2023 17 45 $22,500 $11,705 52.0%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 31 84 $13,440 $7,654 57.0%
90945 Dialysis procedure including 1 evaluation Facility 2023 15 102 $20,400 $6,528 32.0%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 45 45 $7,425 $3,707 49.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 37 38 $5,700 $3,705 65.0%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 22 27 $10,125 $3,586 35.4%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 396 3,007 $451,050 $163,410 36.2%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 314 416 $104,000 $42,476 40.8%
90960 Dialysis services, 4 or more physician visits per month (20 years or older) Office 2022 18 95 $47,500 $26,145 55.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 144 249 $31,125 $15,667 50.3%
99238 Hospital discharge day management, 30 minutes or less Facility 2022 121 184 $27,600 $10,118 36.7%
90961 Dialysis services, 2-3 physician visits per month (20 years or older) Office 2022 15 33 $16,500 $7,696 46.6%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 39 44 $16,500 $6,654 40.3%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 36 78 $12,480 $6,137 49.2%
99220 Initial hospital observation care per day, typically 70 minutes Facility 2022 37 40 $18,000 $5,363 29.8%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 53 53 $8,745 $4,388 50.2%
90945 Dialysis procedure including 1 evaluation Facility 2022 11 41 $8,200 $2,731 33.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 18 18 $2,700 $1,783 66.0%
99239 Hospital discharge day management, more than 30 minutes Facility 2022 14 15 $3,750 $1,207 32.2%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 553 3,911 $586,650 $216,496 36.9%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 453 574 $143,500 $59,676 41.6%

About Dr. Mandeep Singh, M.D

Dr. Mandeep Singh, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Northport, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/08/2008. The National Provider Identifier (NPI) number assigned to this provider is 1689825614.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mandeep Singh, M.D has received a total of $1,072 in payments from pharmaceutical and medical device companies, with $46.66 received in 2024. These payments were reported across 25 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,072).

As a Medicare-enrolled provider, Singh has provided services to 5,523 Medicare beneficiaries, totaling 18,922 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.

Practice Information

Products in Payments

  • ELIQUIS (Drug) $246.30
  • ZERBAXA (Drug) $139.48
  • Veklury (Drug) $124.94
  • SAMSCA (Drug) $122.52
  • VYNDAQEL (Drug) $105.93
  • CHANTIX (Drug) $93.37
  • CLEVIPREX (Drug) $88.70
  • GEMTESA (Drug) $46.66
  • XARELTO (Drug) $41.56
  • Velphoro (Drug) $30.24
  • Kerendia (Drug) $20.22
  • KRYSTEXXA (Biological) $12.45

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Northport